Revium Rx (RVRC) Current Assets (2024 - 2025)

Revium Rx's (RVRC) quarterly Current Assets came in at $3.1 million in Q4 2025, down 43.9% year-on-year from $5.5 million in Q4 2024, and down 43.9% quarter-over-quarter from $5.5 million in Q4 2024.

Revium Rx (RVRC) Current Assets (2024 - 2025) Analysis & Trends

Revium Rx has disclosed Current Assets across 2 years of filings, most recently posting $3.1 million for Q4 2025.

  • Current Assets for Q4 2025 came in at $3.1 million, down 43.9% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.1 million (down 43.9% YoY), and the FY2025 annual result was $3.1 million, down 43.9% from the prior year.
  • Current Assets came in at $3.1 million for Q4 2025 at Revium Rx, down from $5.5 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $5.5 million in Q4 2024 to a low of $3.1 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Veeva Systems 24.83 Bn 17.52 Bn 662.02 Mn 8.06 Bn
2 BrightSpring Health Services 13.57 Bn 12.69 Bn 482.22 Mn 2.69 Bn
3 Healthequity 7.20 Bn 6.93 Bn 256.31 Mn 466.53 Mn
4 Hinge Health 5.42 Bn 5.11 Bn 154.23 Mn 540.05 Mn
5 10x Genomics 4.46 Bn 3.92 Bn 106.18 Mn 669.73 Mn
6 Doximity 3.81 Bn 3.06 Bn 125.97 Mn 944.26 Mn
7 Waystar Holding 3.52 Bn 3.36 Bn 268.04 Mn 386.61 Mn
8 Privia Health 2.94 Bn 2.57 Bn 595.71 Mn 966.02 Mn
9 Omnicell 1.76 Bn 1.59 Bn 140.36 Mn 722.30 Mn
10 Revium Rx - - - 3.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.10 Mn
Dec 31, 2024 5.52 Mn